risedronic acid has been researched along with Gastrointestinal Hemorrhage in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Gastrointestinal Hemorrhage: Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Although these agents are generally well tolerated, serious gastrointestinal adverse events, including hospitalization for gastrointestinal bleed, may arise." | 1.35 | Comparative gastrointestinal safety of weekly oral bisphosphonates. ( Brookhart, MA; Cadarette, SM; Katz, JN; Levin, R; Solomon, DH; Stedman, MR; Stürmer, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santos, LAA | 1 |
| Lima, TB | 1 |
| de Carvalho Nunes, HR | 1 |
| Qi, X | 1 |
| Romeiro, FG | 1 |
| Cadarette, SM | 1 |
| Katz, JN | 1 |
| Brookhart, MA | 1 |
| Stürmer, T | 1 |
| Stedman, MR | 1 |
| Levin, R | 1 |
| Solomon, DH | 1 |
1 trial available for risedronic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.
Topics: Bone Density; Bone Density Conservation Agents; Esophageal and Gastric Varices; Esophagitis; Gastroi | 2022 |
1 other study available for risedronic acid and Gastrointestinal Hemorrhage
| Article | Year |
|---|---|
Comparative gastrointestinal safety of weekly oral bisphosphonates.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Diphos | 2009 |